MediWound (MDWD) Projected to Post Earnings on Wednesday

MediWound (NASDAQ:MDWD) is expected to release its earnings data before the market opens on Wednesday, March 19th. Analysts expect MediWound to post earnings of ($0.61) per share and revenue of $5.79 million for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

MediWound Stock Performance

Shares of NASDAQ:MDWD opened at $18.54 on Monday. The company’s fifty day moving average is $18.04 and its 200-day moving average is $17.58. The company has a market capitalization of $199.97 million, a PE ratio of -6.39 and a beta of 0.82. MediWound has a 52 week low of $12.78 and a 52 week high of $24.00.

Wall Street Analyst Weigh In

MDWD has been the topic of several research reports. HC Wainwright reiterated a “buy” rating and set a $25.00 price target on shares of MediWound in a research report on Friday, January 10th. Craig Hallum initiated coverage on shares of MediWound in a research report on Friday, February 28th. They set a “buy” rating and a $39.00 price target on the stock.

About MediWound

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.